🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent summary of our work led by Mohammadreza Naderian by Marios Georgakis Patients & providers were able to act on an integrated risk score for CHD that included PRS, leading to⬆️in statin use ➡️ lower LDL and ⬇️ CV events More RCTs are needed to assess clinical utility of PRS

Work by K. Norland Fxn annotat improved PGS for cardiometabolic traits but did not ⬇️ disparity in performance btwn genetic ancestry groups Despite heritability enrichment, tissue & cell type-specific snATAC-seq & eQTL annotat provided marginal gains beyond gnl genomic annotat

Congratulations to the amazing Mohammadreza Naderian for this well deserved recognition!

I don’t care whether it comes from Democrats or Republicans—someone in government needs to start addressing this issue. Who is willing to step up?

New study in NEJM demonstrates that a PRS in the top decile was better than PSA/MRI in detection of clinically significant prostate cancer. Highlights utility of a PRS in informing screening for early detection of Prostate Cancer nejm.org/doi/full/10.10…

Admixture in humans is widespread & every individual is admixed to some degree A review by Yun Li et al of methods for local ancestry inference (LAI) & how LAI can be used for admixture mapping, association testing, and for calculating polygenic risk scores PRIMED Consortium

🧵1/ From 2000–2022, Black Americans experienced 779,387 excess cardiovascular deaths— 23.7m years of potential life lost (YPLL). These are more than numbers. They are lives. Families. Futures. #Disparities New JACC Journals Editor’s Page: 👉 authors.elsevier.com/a/1kwz92d9GI27…

CVI's Highlighted #PapersoftheWeek rdcu.be/egHer

How to Live Healthier for Longer - The NYT by ⁦Eric Topol⁩ Scientific advances in risk assessment & personalized interventions can increase Health Span These advances were made possible by investment in biomedical research Support ⁦NIH⁩! nytimes.com/2025/04/21/opi…

Happy #DNADay25 from the PRIMED Consortium Consortium! Genetic information can help improve risk prediction for a broad range of health outcomes. Learn more: 🧬 Publications: primedconsortium.org/publications/p… 🧬 Research Highlights: primedconsortium.org/research/highl…

Excited to reconnect with my #NLA family 🌟 See you soon 🔥 lipid.org/meetings/sessi… There is still time to register🔑 Eugenia Gianos MD Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA Michael Wilkinson Dan Soffer Dr. James Underberg Anandita Agarwala Kulkarni, MD FACC Dinesh Kalra, MD Christie Ballantyne

Makes me feel good as I have been preaching this for > two decades. So many are wasting so many health care dollars by routinely ordering LDL sizes. ApoB, without particle sizes, is the needed test routinely and Lp(a) once.

We have an opportunity to save more lives around the world than ever before—and I want to do even more to help. That's why I'm giving away virtually all of my wealth through the Gates Foundation over the next 20 years.

📢 HPRC Release 2 is here! Now with phased genomes from 200+ individuals, a 5x increase from Release 1. Explore sequencing data, assemblies, annotations & alignments in our interactive data explorer ⬇️: humanpangenome.org/hprc-data-rele…

Congratulations Thais! Shining brightly as always!

Congratulations to Kiran Musunuru and Team on this terrific work to create a bespoke adenine base editor to help a baby. Remarkable story of translation of science to clinical impact. I am particularly proud as Kiran was the first research trainee (post-doctoral fellow) in my

Amazing work and congratulations to Kiran Musunuru !

Following the #EASCongress2025, we’re pleased to share that Phase 2a and preclinical data from our MAR001 program have been published in The Lancet and eBioMedicine – The Lancet Discovery Science, respectively. A sincere thank you to the Marea team members, clinical trial investigators and patients who have

New online! Functional synonymous mutations and their evolutionary consequences bit.ly/43Dlee0

Don't miss our Expert Theaters at #NLASessions! Learn more about the latest innovations in #lipidology while enjoying a delicious meal on us!🔬🍽️ 📅Add these events to your calendar at lipid.org/meetings/sessi….